FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and is a composition for men aimed at improving the functional state of the organs of the male reproductive system containing carnitine tartrate, zinc sulfate, alpha-tocopherol acetate, folic acid, sodium selenite, and auxiliaries, the components in the composition being in a certain ratio, in milligrams per one sachet of 5,000 mg.
EFFECT: invention provides an improvement in the functional state of the organs of the male reproductive system with an additional effect of harmonizing the organoleptic perception of the composition.
1 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR IMPORVEMENT OF HUMAN REPRODUCTION | 2016 |
|
RU2616521C1 |
| USE OF OXIDISED DEXTRAN FOR TREATING AND PREVENTING INFECTIOUS-INFLAMMATORY DISORDERS OF SPERMATOGENESIS | 2023 |
|
RU2814617C1 |
| APPLICATION OF "OYSTER MYCELIUM "REVITACEL" BASED ON PLEUROTUS OSTREATUS FUNGUS STRAIN VKPM F-819, HAVING EFFECT ON MALE REPRODUCTIVE FUNCTION | 2016 |
|
RU2634384C1 |
| RECTAL MEDICINAL AGENT FOR CORRECTION OF SPERMATOGENESIS DISORDERS IN MALE INFERTILITY | 2017 |
|
RU2686334C2 |
| FUNGUS PLEUROTUS 1137-BASED MEDICATION, INFLUENCING MALE REPRODUCTIVE FUNCTION | 2010 |
|
RU2422151C1 |
| REPRODUCTIVE FUNCTION ENHANCER | 2019 |
|
RU2728709C1 |
| METHOD FOR SPERMATOGENESIS CORRECTION IN ANIMALS IN CHRONIC NATURAL GAS POISONING | 2012 |
|
RU2480221C1 |
| METHOD FOR THE TREATMENT OF IDIOPATHIC MALE INFERTILITY IN THE FORM OF OLIGOSPERMIA, OLIGOZOOSPERMIA AND/OR ASTHENOZOOSPERMIA | 2020 |
|
RU2757455C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING EXHIBITING PROPERTY OF ENDOTHELIAL DYSFUNCTION REDUCTION ACCOMPANYING CARDIOVASCULAR DISEASES | 2011 |
|
RU2505290C2 |
| DIETARY AND PROPHYLACTIC FOOD PRODUCT FOR REGENERATION OF REPRODUCTIVE FUNCTIONS OF MALES AND FEMALES | 2009 |
|
RU2403805C1 |
